The Role Of The Clergy In Cancer Management And Rehabilitation

1979 ◽  
Author(s):  
Emmett M. WAITS
Keyword(s):  
2021 ◽  
Vol 3 (2) ◽  
pp. 25-32
Author(s):  
Katarzyna Kuźlik-Gołębiowska ◽  
Anna Jurkowska ◽  
Dariusz Gołębiowski ◽  
Katarzyna Sklinda ◽  
Jerzy Walecki ◽  
...  

Multiparametric magnetic resonance imaging with VI-RADS is a newly discussed method of diagnosing bladder cancer. There are more studies suggesting implementation of mpMRI with VI-RADS to the modern scheme of treating bladder cancer. It requires much more observation and trials to give a final recommendations. The aim of the summary is to present VI-RADS scale and possibilities that appear with the method. Many studies, that were made by departments of urology or radiology, showed promising results. Background: estimation of bladder cancer depends on proper tumor staging, grading and assessment of its biological potential. It is provided by a multimodal approach using clinical, histopathological and radiological methods. Development of MRI provides the best imaging technique for locoregional staging in several other tumors. Lately it was adjusted in BCa preoperative evaluation leading to significant improvement in differentiating patients with NMIBCs and MIBCs. Objective: this article aims to approximate the fundamentals of MRI in BCa and to provide an overview of the available data on the role of VI-RADS score in the diagnostic pathway of bladder cancer.


2014 ◽  
Vol 2 (4) ◽  
pp. 215-224
Author(s):  
Mohammed Husain G ◽  
Abdul Waheed M

Context: Increasing numbers of cancer patients are looking towards traditional medicines (TM) in an effort to sustain tumour remission or halt the metastasis. TM such as Chinese Traditional Medicines, Ayurveda and Unani Medicines are being used in many parts of world from centuries. However, scientific data is lacking for the clinical use of majority of these medicines in cancer management and systematic clinical evaluation is mandatory before recommending long term use. Objective: The role of traditional medicine for prevention and management of cancer are reviewed in this paper which will help to take a step further to bring these TM into mainstream therapy. Methods: Traditional knowledge about the claims of therapeutic potential is collected. Emphasis was given to the use of plant derived products. Further efforts were made to identify the driving factors for use of such TM for the cure of cancer. Results: There are several driving factors which attract patients towards TM out of which minimum side effects of TM remains on the priority. Apart from being used as standalone therapy, TM is progressively becoming more popular as adjuvant therapy to improve effectiveness of conventional treatment and to reduce the side effects of chemotherapy or radiation therapy. Conclusion: Patients are inclining towards TM due to diverse reasons. The search for anticancer drugs from herbs has been very productive and advances in pharmacological techniques have exerted enormous drive on the research and development of new biologically active compounds of plant origin, which may act alone or in synergistic manner.


2020 ◽  
Vol 10 (17) ◽  
pp. 6009
Author(s):  
Malgorzata Anna Krawczyk ◽  
Agata Pospieszynska ◽  
Małgorzata Styczewska ◽  
Ewa Bien ◽  
Sambor Sawicki ◽  
...  

Exosomal heat shock proteins (Hsps) are involved in intercellular communication both in physiological and pathological conditions. They play a role in key processes of carcinogenesis including immune system regulation, cell differentiation, vascular homeostasis and metastasis formation. Thus, exosomal Hsps are emerging biomarkers of malignancies and possible therapeutic targets. Adolescents and young adults (AYAs) are patients aged 15–39 years. This age group, placed between pediatric and adult oncology, pose a particular challenge for cancer management. New biomarkers of cancer growth and progression as well as prognostic factors are desperately needed in AYAs. In this review, we attempted to summarize the current knowledge on the role of exosomal Hsps in selected solid tumors characteristic for the AYA population and/or associated with poor prognosis in this age group. These included malignant melanoma, brain tumors, and breast, colorectal, thyroid, hepatocellular, lung and gynecological tract carcinomas. The studies on exosomal Hsps in these tumors are limited; however; some have provided promising results. Although further research is needed, there is potential for future clinical applications of exosomal Hsps in AYA cancers, both as novel biomarkers of disease presence, progression or relapse, or as therapeutic targets or tools for drug delivery.


Sign in / Sign up

Export Citation Format

Share Document